Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FLT PET Imaging in Solid Tumors and Lymphoma
NCT01065805Phase 2Terminated
- Sponsor
- American Health Staffing Group
- Start
- Mar 2009
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorothymidine F-18 in lung cancer, breast cancer, renal cell carcinoma (RCC), pancreatic cancer (PC), brain cancer, sponsored by American Health Staffing Group. Started Mar 2009; status: terminated.
02
Drugs
fluorothymidine F-18
03
Conditions
lung cancerbreast cancerrenal cell carcinoma (RCC)pancreatic cancer (PC)brain cancer
Beyond the preview
Go deeper on NCT01065805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01065805.